Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Ashok Leyland - Growth outlook remains positive - ICICI Securities

Posted On: 2021-06-27 06:32:09 (Time Zone: UTC)


Ashok Leyland's (AL) Q4FY21 operating performance was a beat to consensus estimates as EBITDA margin came in at 7.6%. The earnings call shed more light into management outlook towards growth, few key thoughts are: a) focus on market share gains led by LCV segment (new product launches under the Bada Dost brand), b) margins have strong levers : i)better mix (higher LCV share), ii)lower fixed costs, iii)superior sourcing efficiencies due to AVTR platform, c) exports remain a key focus area led by the African and MENA region; new (6-7) distributor expansion is likely to drive growth in FY22E, d) dedicated freight corridor is unlikely to have any major impact in industry volumes. AL remains a good proxy play to a cyclical recovery in autos. Valuations are reasonable (FY23: FCF yield: 6%). Maintain BUY.

Key highlights of earnings call:

- AL's M&HCV Q4FY21 volumes grew 111% YoY to reach market share of 28.9% vis--vis 27.6% YoY (Market share for FY21 was up 0.8% at 28.9%). Superior TCO delivery and better fluid efficiency has led to success of the AVTR platform. LCV demand was driven by e-commerce and growth in rural economy, LCV volumes were up 7% with the launch of Bada Dost (4.5k units sold in Q4).

- On margins, LCV business is significantly more profitable vis--vis MHCV. Industry pricing behaviour in M&HCV has remained weak in Q4; however, management expects the same to improve as demand improves. Fixed cost reduction exercises continue across various programs (e.g. parts sourcing, design) which would aid margins amidst cost increases in commodity prices.

- On exports, AVTR and Phoenix platforms have strong capabilities for exports; AL is increasing distribution network in key regions like Africa (6-7 new distributors added in Africa/ MENA region in FY21).

- Capex in FY21 was Rs6.2bn (FY20: ~Rs13bn) while investments stood at ~Rs3.7bn (FY20: ~Rs4.5bn). Net debt in FY21: Rs26bn (0.37x). Capex for FY22 is expected to be Rs7.5bn as AL has no plans for any major brownfield or greenfield expansion. Investment in subsidiaries is likely to reach Rs2-2.5bn (including HLFL).

- Inventory levels at factory stood at 3.4k units. AL took price increases in Q3 and Q4 to partially offset continued commodity price hikes.

- The dedicated freight corridor (DFC) is unlikely to impact AL sales as existing load from current passenger line is expected to shifted to DFC.

- AL has witnessed strong performance in power solutions business with a dominant share in construction engines. In defence segment, stallion and super stallion range are strong brands; AL plans to expand its armoured vehicle offering in FY22/23.

Outlook and valuations

We believe H2FY22E could mark the start of a multi-year upcycle in M&HCV demand. We value the core business at 14x FY23E EV/EBITDA on improving CV cycle outlook and add Rs6/share for investments to arrive at an SoTP-based target price of Rs143. We maintain our BUY rating on the stock.

Upside risks: Well incentivised scrappage policy, faster CV upcycle.

Downside risks: Slower than expected margin improvement, market share loss.

Shares of ASHOK LEYLAND LTD. was last trading in BSE at Rs.123.35 as compared to the previous close of Rs. 118.2. The total number of shares traded during the day was 6280898 in over 26328 trades.

The stock hit an intraday high of Rs. 129.35 and intraday low of 122. The net turnover during the day was Rs. 786427665.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.


Other Headlines:

InterGlobe Aviation - Weak quarter, awaiting timelines for fundraise - HDFC Securities

Maintain REDUCE on IndusInd Bank - Reversion to steady state profitability elusive - HDFC Securities

Dr. Reddy's Labs - Weak quarter; outlook intact - HDFC Securities

Maintain BUY on DLF - Robust performance - HDFC Securities

Maintain BUY on Zensar Technologies - Changing the orbit - HDFC Securities

Maintain ADD on TTK Prestige - Steady revenue; miss in margin - HDFC Securities

Maintain ADD on Torrent Pharma - In-line quarter; positive outlook reaffirmed - HDFC Securities

Navin Fluorine International - High opex dents margin - HDFC Securities

Mahindra & Mahindra Financial Services - Portfolio stress peaking out - HDFC Securities

Maintain ADD on Multi Commodity Exchange - Recovery expected - HDFC Securities

Q1FY22 Result Update - Axis Bank - ICICI Direct

Q1FY22 Result Update - Alembic Pharma - ICICI Direct

Q1FY22 Result Update - Larsen & Toubro - ICICI Direct

Quant Pick - Jindal Steel & Power - ICICI Direct

Q1FY22 Company Update - Phillips Carbon Black - ICICI Direct

Q1FY22 Company Update - Zensar Technologies - ICICI Direct

IPO Review - Rolex Rings Ltd - ICICI Direct

Q1FY22 Result Update - Symphony Ltd - ICICI Direct

Coforge Ltd - Q1FY22 First Cut - ICICI Direct

Q2CY21 Company Update - Sanofi India - ICICI Direct

Q1FY22 Result Update - TTK Prestige - ICICI Direct

Greenlam Industries - Q1 FY22 Result Report - YES Securities

Dixon Technologies - Q1 FY22 Result Report - YES Securities

Dr Reddys' Labs - Q1 FY22 Result Report - YES Securities

TTK Prestige - Q1 FY22 Result Report - YES Securities

DLF Ltd - Q1 FY22 Result Report - YES Securities

Torrent Pharma - Q1 FY22 Result Report - YES SEcurities

Mahindra & Mahindra Financial Services - Q1 FY22 Result Report - YES Securities

IndusInd Bank - Q1 FY22 Result Report - YES Securities

Maintain REDUCE on Kotak Mahindra Bank - Strong profitability but growth remains elusive - HDFC Securities

Maintain BUY on Crompton Consumer - ECD continues to be the torchbearer; miss in lighting - HDFC Securities

Maintain BUY on Axis Bank - Back to square one - HDFC Securities

Maintain ADD on United Spirits - In-line volume; mix impacts margin - HDFC Securities

Maintain BUY on Tata Motors - A weak quarter on expected lines; 2H recovery at JLR - HDFC Securities

Maintain ADD on Symphony - Lost summer hampers domestic momentum - HDFC Securities

SBI Life Insurance - Impressive protection share drives margin beat! - HDFC Securities

Maintain BUY on ICICI Bank - Negative surprise on asset quality likely to be transient - HDfC Securities

DLF - Strong show in challenging quarter - ICICI Securities

Stock Tales - Techno Electric & Engineering - ICICI Direct

Quant Pick - Coal India - ICICI Direct

Q1FY22 Result Update - SKF India - ICICI Direct

Q1FY22 Company Update - Saregama India - ICICI Direct

Q1FY22 Result Update - Crompton Greaves Consumer - ICICI Direct

Q1FY22 Result Update - Ambuja Cements - ICICI Direct

Q1FY22 Result Update - SBI Life Insurance - ICICI Direct

Q1FY22 Result Update - Kotak Mahindra Bank - ICICI Direct

Q1FY22 Result Update - Tata Motors - ICICI Direct

Q1FY22 Result Update - Multi Commodity Exchange - ICICI Direct

Company Update - V-Mart - ICICI Direct

Apollo Pipes Ltd Q1FY22 Result First-Cut - YES Securities


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020